These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 4304934)

  • 21. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mixed vaccinations].
    Labusquière R
    Bull Int Union Tuberc; 1973 Dec; 48 Suppl():55-7. PubMed ID: 4803722
    [No Abstract]   [Full Text] [Related]  

  • 23. RESPONSE OF VOLTA CHILDREN TO JET INOCULATION OF COMBINED LIVE MEASLES, SMALLPOX AND YELLOW FEVER VACCINES.
    MEYER HM; HOSTETLER DD; BERNHEIN BC; ROGERS NG; LAMBIN P; CHASSARY A; LABUSQUIERE R; SMADEL JE
    Bull World Health Organ; 1964; 30(6):783-94. PubMed ID: 14215185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 25. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 26. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral immunization against smallpox.
    Hochstein-Mintzel V; Stickl H; Huber HC
    Dev Biol Stand; 1976; 33():260-6. PubMed ID: 182585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of extremely attenuated live measles virus vaccine (CAM-EX).
    Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
    Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
    [No Abstract]   [Full Text] [Related]  

  • 29. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
    Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
    Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
    [No Abstract]   [Full Text] [Related]  

  • 30. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 31. The response of children to a reduced dose of measles vaccine given with and without other vaccines. (pilot study).
    Cruickshank JG; Dalton H; Lochrie G; Campbell I
    Cent Afr J Med; 1974 Oct; 20(10):201-2. PubMed ID: 4426084
    [No Abstract]   [Full Text] [Related]  

  • 32. Ring vaccination versus mass vaccination in event of a smallpox attack.
    Lau CY; Wahl B; Foo WK
    Hawaii Med J; 2005 Feb; 64(2):34-6, 53. PubMed ID: 15871566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.
    Hsieh SM; Chen SY; Sheu GC; Hung MN; Chou WH; Chang SC; Hsu KH
    Vaccine; 2006 Jan; 24(4):510-5. PubMed ID: 16139395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current problems of vaccination].
    Grahneis H
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):510-6. PubMed ID: 4398882
    [No Abstract]   [Full Text] [Related]  

  • 36. Development and evaluation of the Moraten measles virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
    JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
    Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
    Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
    [No Abstract]   [Full Text] [Related]  

  • 38. [Measles vaccination].
    Enders G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccination of seropositive children against measles in Tanzania: boosting of antibody titres or a statistical artifact.
    Mandara MP; Remme J
    East Afr Med J; 1985 Jan; 62(1):12-20. PubMed ID: 4006810
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of two kinds of smallpox vaccine: CVI-78 and calf lymph vaccine. I. Clinical and serologic response to primary vaccination.
    Wesley RB; Speers WC; Neff JM; Ruben FL; Lourie B
    Pediatr Res; 1975 Aug; 9(8):624-8. PubMed ID: 1098000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.